DK0785794T3 - Entero-coatede præparater af 1,5-benzodiazepinderivater med CCK-antagonistisk eller agonistisk virkning - Google Patents

Entero-coatede præparater af 1,5-benzodiazepinderivater med CCK-antagonistisk eller agonistisk virkning

Info

Publication number: DK0785794T3
Authority: DK; Denmark
Prior art keywords: entero; benzodiazepine derivatives; agonistic effect; coated preparations; cck
Prior art date: 1994-10-14

Application number

DK95935725T

Other languages

Danish (da)

English (en)

Inventor

Elizabeth Ellen Sugg

Original Assignee

Glaxo Wellcome Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-14

Filing date

1995-10-13

Publication date

2002-03-18

1995-10-13 Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc

2002-03-18 Application granted granted Critical

2002-03-18 Publication of DK0785794T3 publication Critical patent/DK0785794T3/da

Links

ZVAPWJGRRUHKGP-UHFFFAOYSA-N 1h-1,5-benzodiazepine Chemical class N1C=CC=NC2=CC=CC=C12 ZVAPWJGRRUHKGP-UHFFFAOYSA-N 0.000 title 1
230000001270 agonistic effect Effects 0.000 title 1
230000003042 antagnostic effect Effects 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
239000002775 capsule Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
239000002702 enteric coating Substances 0.000 abstract 1
238000009505 enteric coating Methods 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000007909 solid dosage form Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Diabetes (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Child & Adolescent Psychology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK95935725T 1994-10-14 1995-10-13 Entero-coatede præparater af 1,5-benzodiazepinderivater med CCK-antagonistisk eller agonistisk virkning DK0785794T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB9420748A GB9420748D0 (en)	1994-10-14	1994-10-14	1,5 benzodiazepine derivatives
PCT/US1995/012829 WO1996011701A1 (en)	1994-10-14	1995-10-13	Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity

Publications (1)

Publication Number	Publication Date
DK0785794T3 true DK0785794T3 (da)	2002-03-18

Family

ID=10762855

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95935725T DK0785794T3 (da)	1994-10-14	1995-10-13	Entero-coatede præparater af 1,5-benzodiazepinderivater med CCK-antagonistisk eller agonistisk virkning

Country Status (11)

Country	Link
EP (1)	EP0785794B1 (de)
JP (1)	JP3907700B2 (de)
AT (1)	ATE210986T1 (de)
AU (1)	AU3763495A (de)
DE (1)	DE69524781T2 (de)
DK (1)	DK0785794T3 (de)
ES (1)	ES2170168T3 (de)
GB (1)	GB9420748D0 (de)
PT (1)	PT785794E (de)
SI (1)	SI0785794T1 (de)
WO (1)	WO1996011701A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6558952B1 (en) *	1992-12-14	2003-05-06	Waratah Pharmaceuticals, Inc.	Treatment for diabetes
JP4530433B2 (ja) *	1996-05-07	2010-08-25	プリヴァ・ディー・ディー	脂質及びグルコースの代謝疾患治療のための方法及び組成物
SG10201913587WA (en)	2016-02-05	2020-02-27	Denali Therapeutics Inc	Inhibitors of receptor-interacting protein kinase 1
DK3552017T3 (da)	2016-12-09	2022-05-16	Denali Therapeutics Inc	Forbindelser, der er anvendelige som ripk1-inhibitorer
WO2023137035A1 (en)	2022-01-12	2023-07-20	Denali Therapeutics Inc.	Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GR890100827A (el) *	1988-12-21	1991-03-15	Abbott Lab	Μέ?οδος παραγωγής παραγώγων τετραπεπτιδίων ως ανταγωνιστών CCK.
GB9201180D0 (en) *	1992-01-21	1992-03-11	Glaxo Group Ltd	Chemical compounds
GB9307833D0 (en) *	1993-04-15	1993-06-02	Glaxo Inc	Modulators of cholecystokinin and gastrin

1994
- 1994-10-14 GB GB9420748A patent/GB9420748D0/en active Pending
1995
- 1995-10-13 AT AT95935725T patent/ATE210986T1/de not_active IP Right Cessation
- 1995-10-13 ES ES95935725T patent/ES2170168T3/es not_active Expired - Lifetime
- 1995-10-13 WO PCT/US1995/012829 patent/WO1996011701A1/en not_active Ceased
- 1995-10-13 JP JP51331396A patent/JP3907700B2/ja not_active Expired - Fee Related
- 1995-10-13 DE DE69524781T patent/DE69524781T2/de not_active Expired - Fee Related
- 1995-10-13 AU AU37634/95A patent/AU3763495A/en not_active Abandoned
- 1995-10-13 DK DK95935725T patent/DK0785794T3/da active
- 1995-10-13 SI SI9530576T patent/SI0785794T1/xx unknown
- 1995-10-13 EP EP95935725A patent/EP0785794B1/de not_active Expired - Lifetime
- 1995-10-13 PT PT95935725T patent/PT785794E/pt unknown

Also Published As

Publication number	Publication date
JP3907700B2 (ja)	2007-04-18
WO1996011701A1 (en)	1996-04-25
JPH10511930A (ja)	1998-11-17
DE69524781D1 (de)	2002-01-31
DE69524781T2 (de)	2002-06-20
EP0785794A1 (de)	1997-07-30
PT785794E (pt)	2002-06-28
SI0785794T1 (en)	2002-08-31
GB9420748D0 (en)	1994-11-30
AU3763495A (en)	1996-05-06
ES2170168T3 (es)	2002-08-01
EP0785794B1 (de)	2001-12-19
ATE210986T1 (de)	2002-01-15

Similar Documents

Publication	Publication Date	Title
SE8804629D0 (sv)	1988-12-22	New therapeutically active compounds
YU13695A (sh)	1999-07-28	Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije
IT8619675A0 (it)	1986-03-07	Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale.
ATE198835T1 (de)	2001-02-15	Knochenwachstumsfördernde zusammensetzung
EP0382077A3 (de)	1991-07-31	Diarylsubstituierte heterocyclische Verbindung, ihre Herstellung und Arzneimittel und Kosmetika daraus
IL80149A (en)	1990-11-29	Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
ATE213633T1 (de)	2002-03-15	Lamotrigin haltiges arzneimittel
SE8804628D0 (sv)	1988-12-22	New compounds
ES2062137T3 (es)	1994-12-16	Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
IL113365A (en)	1999-11-30	5-Heterocyclo-1,5-benzodiazepine derivatives their preparation and pharmaceutical compositions containing them
PH27446A (en)	1993-07-02	Compound with gastric acid inhibitory effect
IT9019112A1 (it)	1991-07-19	Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
IT9019793A0 (it)	1990-03-23	Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
DE69524781D1 (de)	2002-01-31	Zubereitungen von 1,5-benzodiazepinderivaten mit cck-antagonistischen oder agonistischer wirkung mit enterischem überzug
IT8621097A1 (it)	1988-01-10	Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche
NO950177D0 (no)	1995-01-17	Farmakologisk aktive erivater
IT9021021A0 (it)	1990-07-23	Composizioni farmaceutiche per la somministrazione orale di irudina
TR199900013T2 (xx)	1999-04-21	Yeni bile�ikler.
PT1117420E (pt)	2002-10-31	Composicoes farmaceuticas baseadas em alfa-ciclodextrina para administracao oral de analogos de lh-rh
ITPD920141A0 (it)	1992-07-30	Formulazione farmaceutiche per la somministraziane orale di calcitoni-na
ITMI913306A1 (it)	1993-06-10	Composizioni farmaceutiche per la somministrazione nasale di polipeptidi.
ITMI920214A1 (it)	1993-08-05	Composizioni farmaceutiche stabili per la somministrazione orale di calcitonina
IT8820927A0 (it)	1988-06-10	Composto ad attivita'antiinfiammatoria, procedimento per la sua preparazione e relative composizioni farmaceutiche.